Abstract:Background Bleomycin is a broad-spectrum glycopeptide antitumor antibiotic produced by Streptomyces verticillus . Clinically, the mixture of bleomycin A2 and bleomycin B2 is widely used in combination with other drugs for the treatment of various cancers. As a secondary metabolite, the biosynthesis of bleomycin is precisely controlled by the complex extra-/intracellular regulation mechanisms, it is imperative to investigate the global metabolic and regulatory system involved in bleomycin biosynthesis for increasing bleomycin production. Results N -acetylglucosamine (GlcNAc), the vital signaling molecule controlling the onset of development and antibiotic synthesis in Streptomyces , was found to increase the yields of bleomycins significantly in chemically defined medium. To mine the gene information relevant to GlcNAc metabolism, the DNA sequences of dasR - dasA - dasBCD - nagB and nagKA in S. verticillus were determined by chromosome walking. From the results of Real time fluorescence quantitative PCR (RT-qPCR) and electrophoretic mobility shift assays (EMSAs), the repression of the expression of nagB and nagKA by the global regulator DasR was released under induction with GlcNAc. The relief of blmT expression repression by BlmR was the main reason for increased bleomycin production. DasR, however, could not directly affect the expression of the pathway-specific repressor BlmR in the bleomycins gene cluster. With at the beginning of bleomycin synthesis, the supply of the specific precursor GDP-mannose played the key role in bleomycin production. Genetic engineering of the GDP-mannose synthesis pathway indicated that phosphomannose isomerase (ManA) and phosphomannomutase (ManB) were key enzymes for bleomycins synthesis. Here, the blmT , manA and manB co-expression strain OBlmT/ManAB was constructed. Based on GlcNAc regulation and assisted metabolic profiling analysis, the yields of bleomycin A2 and B2 were ultimately increased to 61.79 and 36.9 mg/L, respectively. Conclusions Under GlcNAc induction, the elevated production of bleomycins was mainly associated with the alleviation of the inhibition of BlmT, so blmT and specific precursor synthesis pathways were genetically engineered for bleomycins production improvement. Combination with subsequent metabolomics analysis not only effectively increased the bleomycin yield, but also extended the utilization of chitin-derived substrates in microbial-based antibiotic production.

Genetic Engineering of Streptomyces Bingchenggensis to Produce Milbemycins A3/A4 As Main Components and Eliminate the Biosynthesis of Nanchangmycin

Engineering of primary metabolic pathways for titer improvement of milbemycins in Streptomyces bingchenggensis

The Mildiomycin Biosynthesis: Initial Steps for Sequential Generation of 5-Hydroxymethylcytidine 5′-Monophosphate and 5-Hydroxymethylcytosine in<i>Streptoverticillium rimofaciens</i>ZJU5119

Transcriptome-guided identification of a four-component system, SbrH1-R, that modulates milbemycin biosynthesis by influencing gene cluster expression, precursor supply, and antibiotic efflux

Titer improvement of milbemycins via coordinating metabolic competition and transcriptional co‐activation controlled by Streptomyces antibiotic regulatory protein family regulator in Streptomyces bingchenggensis

Preliminary Study on Milbemycin Biosynthesis of Streptomyces Milbemycinicus DSM41911

Three new milbemycins from a genetically engineered strain S . avermitilis MHJ1011

'Streptomyces Nanchangensis', a Producer of the Insecticidal Polyether Antibiotic Nanchangmycin and the Antiparasitic Macrolide Meilingmycin, Contains Multiple Polyketide Gene Clusters.

Identification of a Gene Cluster Encoding Meilingmycin Biosynthesis among Multiple Polyketide Synthase Contigs Isolated from Streptomyces Nanchangensis NS3226

Analysis of the Mildiomycin Biosynthesis Gene Cluster in Streptoverticillum Remofaciens ZJU5119 and Characterization of MilC, a Hydroxymethyl Cytosyl‐glucuronic Acid Synthase

Genetic Engineering of Streptomyces ghanaensis ATCC14672 for Improved Production of Moenomycins

Enhancement of Bleomycin Production in Streptomyces Verticillus Through Global Metabolic Regulation of N -Acetylglucosamine and Assisted Metabolic Profiling Analysis

MilR2, a novel TetR family regulator involved in 5-oxomilbemycin A3/A4 biosynthesis in Streptomyces hygroscopicus

Elimination of Indigenous Linear Plasmids in Streptomyces Hygroscopicus Var. Jinggangensis and Streptomyces Sp. FR008 to Increase Validamycin A and Candicidin Productivities.

Engineering Validamycin Production by Tandem Deletion of Γ-Butyrolactone Receptor Genes in Streptomyces Hygroscopicus 5008

Adaptive Optimization Boosted the Production of Moenomycin A in the Microbial Chassis Streptomyces Albus J1074.

Engineering the methyltransferase through inactivation of the genK and genL leads to a significant increase of gentamicin C1a production in an industrial strain of Micromonospora echinospora 49-92S

Cloning of Separate Meilingmycin Biosynthesis Gene Clusters by Use of Acyltransferase-Ketoreductase Didomain Pcr Amplification

Overproduction of lactimidomycin by cross-overexpression of genes encoding Streptomyces antibiotic regulatory proteins

Overproduction of Gentamicin B in Industrial Strain Micromonospora Echinospora CCTCC M 2018898 by Cloning of the Missing Genes Genr and Gens

Enhanced amphotericin B production by genetically engineered Streptomyces nodosus